Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet's Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils.

Passet M, Lepelletier C, Vignon-Pennamen MD, Chasset F, Hirsch P, Battistella M, Duriez P, Sicre de Fontbrune F, Boissel N, Legrand O, Raffoux E, Bagot M, Adès L, Clappier E, Bouaziz JD.

J Invest Dermatol. 2020 Feb 17. pii: S0022-202X(20)30149-4. doi: 10.1016/j.jid.2019.12.040. [Epub ahead of print] No abstract available.

PMID:
32081610
2.

Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program.

Robin C, Thiebaut A, Alain S, Sicre de Fontbrune F, Berceanu A, D'Aveni M, Ceballos P, Redjoul R, Nguyen-Quoc S, Bénard N, Pahlavan-Grumel G, Cordonnier C.

Biol Blood Marrow Transplant. 2020 Feb 5. pii: S1083-8791(20)30060-4. doi: 10.1016/j.bbmt.2020.01.027. [Epub ahead of print]

PMID:
32035273
3.

Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.

Debureaux PE, Brignier A, Soret-Dulphy J, Réa D, Michonneau D, Peffault de Latour R, Sicre de Fontbrune F, Pagliuca S, Parquet N, Prata HP, Marouf A, Xhaard A, Kiladjian JJ, Socié G, Robin M.

Ann Hematol. 2020 Apr;99(4):897-898. doi: 10.1007/s00277-020-03948-0. Epub 2020 Feb 7. No abstract available.

PMID:
32030449
4.

HSCT may lower leukemia risk in ELANE neutropenia: a before-after study from the French Severe Congenital Neutropenia Registry.

Rotulo GA, Beaupain B, Rialland F, Paillard C, Nachit O, Galambrun C, Gandemer V, Bertrand Y, Neven B, Dore E, Moshous D, Filhon B, Aladjdi N, Sicre de Fontbrune F, de la Tour RP, Ouachee M, Bellanne-Chantelot C, Dalle JH, Donadieu J.

Bone Marrow Transplant. 2020 Jan 28. doi: 10.1038/s41409-020-0800-1. [Epub ahead of print]

PMID:
31992846
5.

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.

Röth A, Nishimura JI, Nagy Z, Gaàl-Weisinger J, Panse J, Yoon SS, Egyed M, Ichikawa S, Ito Y, Kim JS, Ninomiya H, Schrezenmeier H, Sica S, Usuki K, Sicre de Fontbrune F, Soret J, Sostelly A, Higginson J, Dieckmann A, Gentile B, Anzures-Cabrera J, Shinomiya K, Jordan G, Biedzka-Sarek M, Klughammer B, Jahreis A, Bucher C, Peffault de Latour R.

Blood. 2020 Mar 19;135(12):912-920. doi: 10.1182/blood.2019003399.

6.

Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial.

Peffault de Latour R, Chevret S, Ruggeri AL, Suarez F, Souchet L, Michonneau D, Sicre de Fontbrune F, Coman T, Dhedin N, Rubio MT, Nguyen S, Mohty M, Socié G.

Blood. 2020 Jan 16;135(3):227-229. doi: 10.1182/blood.2019000358. No abstract available.

PMID:
31805185
7.

Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis.

Borie R, Kannengiesser C, Gouya L, Dupin C, Amselem S, Ba I, Bunel V, Bonniaud P, Bouvry D, Cazes A, Clement A, Debray MP, Dieude P, Epaud R, Fanen P, Lainey E, Legendre M, Plessier A, Sicre de Fontbrune F, Wemeau-Stervinou L, Cottin V, Nathan N, Crestani B.

Orphanet J Rare Dis. 2019 Dec 3;14(1):280. doi: 10.1186/s13023-019-1256-5.

8.

Aplastic anemia related to thymoma: a survey on behalf of the French reference center of aplastic anemia and review of literature.

Gendron N, Sicre de Fontbrune F, Guyard A, Fadlallah J, Chantepie S, D' Aveni M, Le Calloch R, Garnier A, Couturier MA, Morel V, Bernard C, Terriou L, Lazaro E, Socié G, Peffault de Latour R.

Haematologica. 2019 Nov 14. pii: haematol.2019.226134. doi: 10.3324/haematol.2019.226134. [Epub ahead of print] No abstract available.

9.

Germline DDX41 mutations define a significant entity within adult MDS/AML patients.

Sébert M, Passet M, Raimbault A, Rahmé R, Raffoux E, Sicre de Fontbrune F, Cerrano M, Quentin S, Vasquez N, Da Costa M, Boissel N, Dombret H, Peffault de Latour R, Socié G, Itzykson R, Fenaux P, Soulier J, Adès L, Clappier E.

Blood. 2019 Oct 24;134(17):1441-1444. doi: 10.1182/blood.2019000909.

PMID:
31484648
10.

A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.

Xhaard A, Launay M, Sicre de Fontbrune F, Michonneau D, Sutra Del Galy A, Coman T, Pagliuca S, Dhedin N, Robin M, Peffault de Latour R, Socie G.

Bone Marrow Transplant. 2020 Jan;55(1):86-92. doi: 10.1038/s41409-019-0633-y. Epub 2019 Aug 14.

PMID:
31413313
11.

Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions.

Pagliuca S, Michonneau D, Sicre de Fontbrune F, Sutra Del Galy A, Xhaard A, Robin M, Peffault de Latour R, Socie G.

Blood Adv. 2019 Aug 13;3(15):2424-2435. doi: 10.1182/bloodadvances.2019000143. Review.

12.

Chronic graft-versus-host disease and inhibition of interleukin-17: proof of concept in humans.

Debureaux PE, de Masson A, Battistella M, Sicre de Fontbrune F, Socié G, Bouaziz JD, Michonneau D.

Br J Dermatol. 2020 Apr;182(4):1038-1041. doi: 10.1111/bjd.18214. Epub 2019 Aug 25.

PMID:
31175666
13.

Effectiveness of lenalidomide in relapsed primary cutaneous diffuse large B-cell lymphoma, leg type.

Al Dhafiri M, Sicre de Fontbrune F, Marinho E, Deschamps L, Di-Lucca J, Crickx B, Descamps V.

Clin Case Rep. 2019 Apr 5;7(5):964-967. doi: 10.1002/ccr3.2137. eCollection 2019 May.

14.

Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.

Sarasin A, Quentin S, Droin N, Sahbatou M, Saada V, Auger N, Boursin Y, Dessen P, Raimbault A, Asnafi V, Schmutz JL, Taïeb A, Menck CFM, Rosselli F, La Rochelle LD, Robert C, Sicre de Fontbrune F, Sébert M, Leblanc T, Kannouche P, De Botton S, Solary E, Soulier J.

Blood. 2019 Jun 20;133(25):2718-2724. doi: 10.1182/blood-2019-01-895698. Epub 2019 Mar 26. No abstract available.

15.

Nationwide survey in France on the use of romiplostim in patients with refractory severe aplastic anemia.

Zhao LP, Sicre De Fontbrune F, Contejean A, Abraham J, Terriou L, Chabrot C, Charbonnier A, Lengline E, Socié G, Peffault de Latour R.

Bone Marrow Transplant. 2019 Jul;54(7):1161-1163. doi: 10.1038/s41409-019-0452-1. Epub 2019 Jan 22. No abstract available.

PMID:
30670823
16.

Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study.

Lee JW, Sicre de Fontbrune F, Wong Lee Lee L, Pessoa V, Gualandro S, Füreder W, Ptushkin V, Rottinghaus ST, Volles L, Shafner L, Aguzzi R, Pradhan R, Schrezenmeier H, Hill A.

Blood. 2019 Feb 7;133(6):530-539. doi: 10.1182/blood-2018-09-876136. Epub 2018 Dec 3.

17.

Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study.

Xhaard A, Porcher R, Bergeron A, Alanio A, Touratier S, Bretagne S, de Margerie-Mellon C, Sicre de Fontbrune F, Itzykson R, Coman T, Robin M, Cabannes-Hamy A, Socié G, Peffault de Latour R.

Ann Hematol. 2019 Apr;98(4):1033-1035. doi: 10.1007/s00277-018-3530-3. Epub 2018 Oct 23. No abstract available.

PMID:
30353389
18.

Utility and Safety of Liver Biopsy in Patients with Undetermined Liver Blood Test Anomalies after Allogeneic Hematopoietic Stem Cell Transplantation: A Monocentric Retrospective Cohort Study.

Ruggiu M, Bedossa P, Rautou PE, Bertheau P, Plessier A, Peffault de Latour R, Robin M, Sicre de Fontbrune F, Pagliuca S, Villate A, Xhaard A, Socié G, Michonneau D.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2523-2531. doi: 10.1016/j.bbmt.2018.07.037. Epub 2018 Jul 30.

19.

Ten Years of Clinical Experience With Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria.

Sicre de Fontbrune F, Peffault de Latour R.

Semin Hematol. 2018 Jul;55(3):124-129. doi: 10.1053/j.seminhematol.2018.04.001. Epub 2018 Apr 9. Review.

PMID:
30032748
20.

Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study.

Peffault de Latour R, Chevret S, Jubert C, Sirvent A, Galambrun C, Ruggeri A, Gandemer V, Cornillon J, Rialland F, Dalle JH, Forcade E, Bruno B, Paillard C, Rorlich PS, Salmon A, Fürst S, Sicre de Fontbrune F, Rubio MT, Bay JO, Mohty M, Larghero J, Gluckman E, Socié G; Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Blood. 2018 Aug 16;132(7):750-754. doi: 10.1182/blood-2018-01-829630. Epub 2018 May 14.

PMID:
29760162

Supplemental Content

Loading ...
Support Center